Stock Quote (NASDAQ: NSTG)
Price:
19.75
Change:
- 0.02
Day High:
19.98
Day Low:
19.50
Volume:
80,989
4:00 PM ET on Mar 28, 2017
Delayed at least 20 minutes.
Provided by eSignal.


Search Investor Relations

Press Releases

All Releases
View Summary PRESS RELEASEFeb 12, 2016
NanoString Technologies to Release Fourth Quarter 2015 Financial Results and Host Conference Call on Monday, February 29, 2016
read more
View Summary PRESS RELEASEFeb 11, 2016
NanoString Technologies Presents Proof-of-Concept Data for Novel Massively Parallel Single Molecule Sequencing Chemistry at AGBT Meeting
read more
View Summary PRESS RELEASEFeb 09, 2016
American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Recommends Use of Prosigna (PAM50) for Guiding Treatment Decisions in Early Stage Breast Cancer Patients
read more
View Summary PRESS RELEASEJan 27, 2016
NanoString Technologies to Present at the Leerink Partners 5th Annual Global Healthcare Conference
read more
View Summary PRESS RELEASEJan 10, 2016
NanoString Technologies Provides Preliminary Operational and Financial Results for 2015
read more
View Summary PRESS RELEASEJan 07, 2016
NanoString Technologies Enters Into Collaboration Agreement With Medivation and Astellas to Develop Novel Companion Diagnostic Test
read more
View Summary PRESS RELEASEDec 23, 2015
NanoString Technologies to Present at J.P. Morgan 34th Annual Healthcare Conference
read more
View Summary PRESS RELEASEDec 07, 2015
NanoString Technologies Announces Eleven Prosigna/PAM50 Presentations at the 2015 CTRC-AACR San Antonio Breast Cancer Symposium
read more
View Summary PRESS RELEASENov 05, 2015
NanoString Technologies to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
read more
View Summary PRESS RELEASENov 05, 2015
NanoString Technologies Expands 3D Biology Portfolio With the Commercial Launch of Seven New nCounter PanCancer Profiles to Deeply Probe Cancer Biology
read more
View Summary PRESS RELEASENov 02, 2015
NanoString Technologies Releases Financial Results for Third Quarter of 2015
read more
View Summary PRESS RELEASEOct 12, 2015
NanoString Technologies to Release Third Quarter 2015 Financial Results and Host Conference Call on Monday, November 2, 2015
read more
View Summary PRESS RELEASESep 11, 2015
NanoString Technologies to Unveil Strategic Roadmap for Growth and Market Expansion
read more
View Summary PRESS RELEASESep 10, 2015
NanoString Technologies Expands Immuno-Oncology Portfolio With Commercial Launch of Innovative nCounter RNA:Protein PanCancer Immune Profiling Panel
read more
View Summary PRESS RELEASESep 09, 2015
ESMO Clinical Practice Guidelines for Breast Cancer Recommend the Use of Prosigna/PAM50 Assay for Determining Potential Benefit From Chemotherapy
read more
View Summary PRESS RELEASEAug 27, 2015
NanoString Technologies to Host Investor Day on September 11, 2015
read more
View Summary PRESS RELEASEAug 26, 2015
NanoString Technologies to Present at Upcoming Investor Conferences
read more
View Summary PRESS RELEASEAug 13, 2015
NanoString Technologies Receives Favorable Final Local Coverage Determination by Palmetto GBA for Its Prosigna Breast Cancer Assay
read more
View Summary PRESS RELEASEAug 04, 2015
NanoString Technologies Releases Financial Results for Second Quarter of 2015
read more
View Summary PRESS RELEASEJul 30, 2015
NanoString Technologies to Present at the Canaccord Genuity Growth Conference
read more
Showing 41-60 of 184 Page: 1 2 3 4 5 6 7 ... 10  Previous 20 | Next 20